The Evolving Treatment Landscape for Triple-Negative Breast Cancer: New Targeted, Immuno-Oncology, and Emerging Combination Approaches

Aditya Bardia, Sara A Hurvitz, Douglas S Burgoyne, Kelly Valla, Mark A Rubin, Annette Sophin, Joyce M Knestrick
  • Duration: 1h 15m

  • Ref. 201367

1.25 Hours

With the advent of immunotherapy, antibody-drug conjugates, and other targeted therapies, impressive strides have been made to improve historically dismal outcomes among patients with triple-negative breast cancer (TNBC). With additional promising therapeutic strategies on the horizon, it is important to remain up to date with e....

The Emergence of a New Subtype: HER2-Low Breast Cancer

Aditya Bardia, Jane Lowe Meisel, Douglas S Burgoyne, Kelly Valla, Mark A Rubin, Annette Sophin, Joyce M Knestrick
  • Duration: 30m

  • Ref. 201366

0.5 Hours

The current binary classification of positive or negative HER2 status is evolving, and many patients formerly classified as HER2-negative are now considered HER2-low, and may benefit from HER2-targeted therapy. This highlights the importance of accurate biomarker assessment and interpretation to evaluate appropriate treatment op....

Testing Sponsor

Mr WCEA Administrator
  • Ref. 201323

Course Description* Please add a course description with a minimum of 20 characters.

Novel and Emerging Evidence in Early-Stage Breast Cancer

Erika P. Hamilton, Jane Lowe Meisel, Douglas S Burgoyne, Mark A Rubin, Annette Sophin, Michele B Kaufman
  • Duration: 1h

  • Ref. 201360

1 Hours

Novel and emerging therapies are enabling a more individualized approach to care in early-stage breast cancer. As immunotherapy and targeted agents move into earlier lines of treatment, ensure your team is current on evidence-based treatment strategies and updated guideline recommendations. Tune in to Part 1 of 6 of our Breas....

Addressing Persistent Challenges in Treatment and Management of Low-Grade Serous Ovarian Carcinoma to Amplify the Latest Evidence in Emerging Therapies

Kathleen N Moore, David M. Gershenson, Stephanie Joyce, Michele B Kaufman, Ricardo Correa
  • Duration: 1h

  • Ref. 201354

1 Hours

Join us for an exciting on-demand video masterclass designed to revolutionize your approach to ovarian cancer care! Dive into the critical distinctions between low-grade serous ovarian carcinoma (LGSOC) and high-grade serous ovarian carcinoma (HGSOC), and uncover the unique epidemiology, pathophysiology, and disease biology that....

The Silent Sense: Expert Strategies for Recognizing and Diagnosing Neurotrophic Keratitis

Marjan Farid, Francis S Mah, Bruce I Gaynes, Kristi Kay Orbaugh, Brad Boyette
  • Duration: 30m

  • Ref. 201328

0.5 Hours

Neurotrophic keratitis (NK) is a rare, degenerative corneal disease characterized by reduced or absent corneal sensation. Its rarity, potential asymptomatic progression, and nonspecific presentation often cause diagnostic delays. Prompt, appropriate treatment is crucial to prevent irreversible corneal damage. In this first vi....

Tailoring Multiple Sclerosis Treatments Based on Clinical and Patient-Specific Factors

Joseph R Berger, Aaron E Miller, Ricardo Correa, Michele B Kaufman, Kristi Kay Orbaugh
  • Duration: 30m

  • Ref. 201353

0.5 Hours

Navigating treatment options for multiple sclerosis (MS) is a challenging task that is further compounded by individualizing treatment based on the latest clinical evidence as well as patient specific factors. In this 30-minute video, an MS expert will review patient-centered strategies in treatment decision-making and their....

Navigating the Complexities of PH-ILD Diagnosis and Treatment: Implications for Managed Care Professionals

Steven D. Nathan, Michael R Stinchon, Abimbola Farinde, Kristi Kay Orbaugh, Mark A Rubin
  • Duration: 30m

  • Ref. 201348

0.5 Hours

Pulmonary hypertension associated with interstitial lung disease (PH-ILD) is a complex condition due to the overlap of two distinct, often progressive, disease courses. The development of PH in ILD impacts symptoms, functional status, economic burden, and mortality rates to a greater degree than ILD alone. Tune in to this mul....

Examining Cervical Cancer: Guideline-Concordant Screening and Referral Practices

Linda R. Duska, Melissa A. Simon, Abimbola Farinde, Jason Welch, Annette Sophin
  • Duration: 30m

  • Ref. 201343

0.5 Hours

With the frequent changes in cervical cancer screening guidelines in recent years, coupled with widening disparities among vulnerable and high-risk populations, it's more important than ever to stay up to date on current screening guidelines to diagnose cervical cancer early and improve equitable care for vulnerable and high-ris....

Meningococcal Disease Prevention for Adolescents and Young Adults: An Educational Toolkit for Providers

Gary S Marshall, Ricardo Correa, Kristi Kay Orbaugh, and Gabriela Andonie
  • Duration: 1h

  • Ref. 201337

1 Hours

Meningococcal disease, though rare, is a serious bacterial infection preventable through vaccination during adolescence. Despite this, suboptimal vaccination rates continue to leave older adolescents and young adults vulnerable, particularly among those in boarding schools and college campuses. Download this toolkit to access....

HIV Prevention for Black Women: Overcoming Barriers and Enhancing Access

Oni J Blackstock, Jewel Sawyer, Ricardo Correa, Abimbola Farinde, Joyce M Knestrick
  • Duration: 1h

  • Ref. 201341

1 Hours

Despite advancements in HIV prevention, Black women continue to be disproportionately impacted by HIV and face barriers to accessing pre-exposure prophylaxis (PrEP). To address this urgent need, clinicians must be equipped with the knowledge and strategies to elevate awareness and ensure equitable access to HIV prevention and se....

Advancing Lung Cancer Screening: Detection and Management of Early-Stage Lung Cancer

Jacob M. Sands, Michele B Kaufman, Mark A Rubin, Annette Sophin
  • Duration: 1h

  • Ref. 201356

1 Hours

Lung cancer screening with low-dose computed tomography (CT) scanning is crucial for early detection in high-risk individuals and is currently recommended to improve outcomes. Tune in to this expert-led, on-demand video for a discussion on the latest recommendations, guidelines, and best practices related to lung cancer scree....

Navigating the Neurotrophic Keratitis Treatment Landscape: Integrating Innovation and Individualized Care

Marjan Farid, Francis S Mah, Bruce I Gaynes, Kristi Kay Orbaugh, Brad Boyette
  • Duration: 30m

  • Ref. 201324

0.5 Hours

Neurotrophic keratitis (NK) is a rare, progressive corneal disorder that can cause partial or complete vision loss and significantly impact quality of life. Traditionally, treatments have focused on symptom management, but with the approval of a targeted therapy and ongoing research into additional treatments, options now exist....

TOSTA RICA SPONSOR

Mr WCEA Administrator
  • Duration: 30m

  • Ref. 201439

Kathy Wilson BDS PhD MSc MFDS (RCS Edin) DDPH (RC

Lower Body Injury Evaluation and Management - Foot

Suraj Achar, MD
  • Duration: 45m

  • Ref. 197651

This course covers an in depth anatomy of the foot, compares various foot disorders and their diagnosis, treatment and management.

Test Learning Path JH

Mr WCEA Administrator
  • Duration: 2h

  • Ref. 199365

Test Test Test Test Test Test

Amplifying Student Voice

Der Desiree Alexander
  • Duration: 1h

  • Ref. 196886

Student Voice is about letting students be involved and have some kind of control over their own education.

Session 2: Resiliency & PCEs (What you can control)

Karen Beaman
  • Duration: 1h

  • Ref. 199960

We know that we can only control ourselves. Let’s dig into what helps create resiliency, what helped you growing up, and how we can implement PCEs in our classrooms.

Management of Epilepsy in Primary Health Care

MR TIBERRY NYAKWANA
  • Duration: 1h

  • Ref. 198623

Epilepsy is a chronic condition of the brain affecting about 70 million people. It has a significant public health burden where WHO’s Global Burden of Disease ranked it as the second most burdensome neurologic disorder worldwide in terms of disability- adjusted life years (Murray, 2010).Worldwide 70 million people suffer from it....

NCDs and Primary Health Care in Africa

Mr Ferdinant Sonyuy Mbiydzenyuy
  • Duration: 1h

  • Ref. 198772

The session will explain what NCDs are, describe the burden of NCDs globally and in Africa, and then proceed to explain the importance and role of primary healthcare in NCD prevention and in treatment of NCDs. It will conclude with a call to action for PHC practitioners to ensure inclusion and prioritization of NCDs in primary h....

Sickle Cell Anaemia: Disease Complications and Therapeutic Interventions

Dr Garrick Laudin
  • Duration: 1h

  • Ref. 198658

The talk focuses mainly on the multi-organ involvement by sickle cell disease (SCD)/ sickle cell anaemia (SSA) as well as awareness and screening of the disease complications. A brief overview of transfusion therapy and other therapeutic modalities in the management of sickle cell anaemia will be undertaken.

Breast Cancer: What is? & What Works?

National Radiotherapy and Oncology Centre, Korle-Bu Teaching Hospital, Accra
  • Duration: 2h

  • Ref. 197719

Breast Cancer is the foremost cancer in Ghanaian women and the leading cause of cancer death. GLOBOCAN estimated that 4482 women were diagnosed with breast cancer in 2020, representing 18.7 % of all cancers in Ghana. The picture is no different in other African countries. Where it is different, breast cancer is second only to ce....

Hepatitis B (Transmission, Treatment, Lifestyle Modifications and Prevention)

Tumaini Bayasabe
  • Duration: 1h

  • Ref. 199746

This presentation is about Hepatitis B. The aim is to explain its Transmission, Treatment, Lifestyle Modifications and Prevention.

Reversing Type 2 Diabetes with Diet

Dr Roxanne Becker
  • Duration: 1h

  • Ref. 199786

Diabetes is the second leading cause of death in South Africa and among the top leading causes of death globally. From surgical wards to obstetric wards, you are guaranteed to encounter it. Traditionally, the role of type 2 diabetes management is to control glucose and prevent complications from developing, but recent evidence....

Teaching Toileting Skills for Autistic and Neurodivergent Individuals

Anderson Center Consulting & Training
  • Duration: 1h

  • Ref. 199065

Through this training, parents and caregivers will learn how to determine if an individual is ready for toilet training. A parent/caregiver-friendly approach to teaching toileting skills will be presented, along with strategies to prevent and address common challenges when teaching toileting skills.